After Pruning Orchard, Gaspar Focuses on High Value Opportunities

Bobby Gaspar, founder and CEO of Orchard Therapeutics, discusses the company’s sharpened focus, its gene therapy in development for metachromatic leukodystrophy, and where he sees the greatest opportunities for Orchard going forward